BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Karantanos T, Markoutsaki T, Gazouli M, Anagnou NP, Karamanolis DG. Current insights in to the pathophysiology of Irritable Bowel Syndrome. Gut Pathog. 2010;2:3. [PMID: 20465787 DOI: 10.1186/1757-4749-2-3] [Cited by in Crossref: 47] [Cited by in F6Publishing: 40] [Article Influence: 4.3] [Reference Citation Analysis]
Number Citing Articles
1 Chen J, Chen Z, Ma L, Liang Q, Jia W, Pan Z, Zeng Y, Jiang B. Development of determination of four analytes of Zhi-Shao-San decoction using LC-MS/MS and its application to comparative pharmacokinetics in normal and irritable bowel syndrome rat plasma. Biomed Chromatogr 2014;28:1384-92. [PMID: 24687219 DOI: 10.1002/bmc.3180] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
2 Vaiopoulou A, Karamanolis G, Psaltopoulou T, Karatzias G, Gazouli M. Molecular basis of the irritable bowel syndrome. World J Gastroenterol. 2014;20:376-383. [PMID: 24574707 DOI: 10.3748/wjg.v20.i2.376] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
3 Kumari MV, Amarasiri L, Rajindrajith S, Devanarayana NM. Functional abdominal pain disorders and asthma: two disorders, but similar pathophysiology? Expert Rev Gastroenterol Hepatol 2021;15:9-24. [PMID: 32909837 DOI: 10.1080/17474124.2020.1821652] [Reference Citation Analysis]
4 Al-Hazmi AH. Knowledge, attitudes, and practices of primary care physicians about irritable bowel syndrome in Northern Saudi Arabia. Saudi J Gastroenterol 2012;18:173-81. [PMID: 22626796 DOI: 10.4103/1319-3767.96450] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
5 Cruchet S, Furnes R, Maruy A, Hebel E, Palacios J, Medina F, Ramirez N, Orsi M, Rondon L, Sdepanian V. The use of probiotics in pediatric gastroenterology: a review of the literature and recommendations by Latin-American experts. Paediatr Drugs. 2015;17:199-216. [PMID: 25799959 DOI: 10.1007/s40272-015-0124-6] [Cited by in Crossref: 57] [Cited by in F6Publishing: 33] [Article Influence: 9.5] [Reference Citation Analysis]
6 Long Y, Du L, Kim JJ, Chen B, Zhu Y, Zhang Y, Yao S, He H, Zheng X, Huang Z, Dai N. MLCK-mediated intestinal permeability promotes immune activation and visceral hypersensitivity in PI-IBS mice. Neurogastroenterol Motil 2018;30:e13348. [DOI: 10.1111/nmo.13348] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
7 Ghoshal UC, Shukla R, Ghoshal U, Gwee KA, Ng SC, Quigley EM. The gut microbiota and irritable bowel syndrome: friend or foe? Int J Inflam. 2012;2012:151085. [PMID: 22577594 DOI: 10.1155/2012/151085] [Cited by in Crossref: 85] [Cited by in F6Publishing: 80] [Article Influence: 9.4] [Reference Citation Analysis]
8 Qin HY, Cheng CW, Tang XD, Bian ZX. Impact of psychological stress on irritable bowel syndrome. World J Gastroenterol. 2014;20:14126-14131. [PMID: 25339801 DOI: 10.3748/wjg.v20.i39.14126] [Cited by in CrossRef: 95] [Cited by in F6Publishing: 79] [Article Influence: 15.8] [Reference Citation Analysis]
9 Li Y, Li LS, Zhang XL, Zhang Y, Xu JD, Zhu JX. An enhanced cAMP pathway is responsible for the colonic hyper-secretory response to 5-HT in acute stress rats. Physiol Res 2015;64:387-96. [PMID: 25536313 DOI: 10.33549/physiolres.932863] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
10 Hosseini A, Nikfar S, Abdollahi M. Probiotics use to treat irritable bowel syndrome. Expert Opin Biol Ther. 2012;12:1323-1334. [PMID: 22897430 DOI: 10.1517/14712598.2012.707179] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
11 Andromanakos NP, Pinis SI, Kostakis AI. Chronic severe constipation: current pathophysiological aspects, new diagnostic approaches, and therapeutic options. Eur J Gastroenterol Hepatol 2015;27:204-14. [PMID: 25629565 DOI: 10.1097/MEG.0000000000000288] [Cited by in Crossref: 19] [Cited by in F6Publishing: 5] [Article Influence: 3.2] [Reference Citation Analysis]
12 Stasi C, Bellini M, Costa F, Mumolo MG, Ricchiuti A, Grosso M, Duranti E, Metelli MR, Gambaccini D, Bianchi L. Neuroendocrine markers and psychological features in patients with irritable bowel syndrome. Int J Colorectal Dis. 2013;28:1203-1208. [PMID: 23377858 DOI: 10.1007/s00384-013-1646-4] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 2.6] [Reference Citation Analysis]
13 Breen M, Murphy KP, O’neill SB, O’donovan JP, Mcwilliams S, Desmond AN, Shanahan F, Quigley EM, Maher MM. The utilisation and diagnostic yield of radiological imaging in a specialist functional GI disorder clinic: an 11-year retrospective study. Eur Radiol 2014;24:3097-104. [DOI: 10.1007/s00330-014-3315-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
14 Lopes SS, Miszputen SJ, Sachs A, Lima MM, Ambrogini O. Evaluation of carbohydrate and fiber consumption in patients with irritable bowel syndrome in outpatient treatment. Arq Gastroenterol. 2019;56:3-9. [PMID: 31141064 DOI: 10.1590/s0004-2803.201900000-12] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
15 Sohn W, Lee OY, Kwon JG, Park KS, Lim YJ, Kim TH, Jung SW, Kim JI. Tianeptine vs amitriptyline for the treatment of irritable bowel syndrome with diarrhea: a multicenter, open-label, non-inferiority, randomized controlled study. Neurogastroenterol Motil 2012;24:860-e398. [PMID: 22679908 DOI: 10.1111/j.1365-2982.2012.01945.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
16 Devanarayana NM, Rajindrajith S. Irritable bowel syndrome in children: Current knowledge, challenges and opportunities. World J Gastroenterol. 2018;24:2211-2235. [PMID: 29881232 DOI: 10.3748/wjg.v24.i21.2211] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
17 Koutouratsas T, Kalli T, Karamanolis G, Gazouli M. Contribution of ghrelin to functional gastrointestinal disorders' pathogenesis. World J Gastroenterol 2019;25:539-51. [PMID: 30774270 DOI: 10.3748/wjg.v25.i5.539] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
18 Casén C, Vebø HC, Sekelja M, Hegge FT, Karlsson MK, Ciemniejewska E, Dzankovic S, Frøyland C, Nestestog R, Engstrand L, Munkholm P, Nielsen OH, Rogler G, Simrén M, Öhman L, Vatn MH, Rudi K. Deviations in human gut microbiota: a novel diagnostic test for determining dysbiosis in patients with IBS or IBD. Aliment Pharmacol Ther 2015;42:71-83. [PMID: 25973666 DOI: 10.1111/apt.13236] [Cited by in Crossref: 149] [Cited by in F6Publishing: 135] [Article Influence: 24.8] [Reference Citation Analysis]
19 El-Salhy M, Gundersen D, Gilja OH, Hatlebakk JG, Hausken T. Is irritable bowel syndrome an organic disorder? World J Gastroenterol. 2014;20:384-400. [PMID: 24574708 DOI: 10.3748/wjg.v20.i2.384] [Cited by in CrossRef: 64] [Cited by in F6Publishing: 55] [Article Influence: 9.1] [Reference Citation Analysis]
20 El-Salhy M. Recent advances in the diagnosis of irritable bowel syndrome. Expert Rev Gastroenterol Hepatol 2015;9:1161-74. [PMID: 26162959 DOI: 10.1586/17474124.2015.1067138] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
21 Whitehead WE, Duffy K, Sharpe J, Nabata T, Bruce M. Randomised clinical trial: exploratory phase 2 study of ONO-2952 in diarrhoea-predominant irritable bowel syndrome. Aliment Pharmacol Ther 2017;45:14-26. [PMID: 27910150 DOI: 10.1111/apt.13839] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 2.2] [Reference Citation Analysis]
22 Mazor Y, Hansen R, Prott G, Kellow J, Malcolm A. The importance of a high rectal pressure on strain in constipated patients: implications for biofeedback therapy. Neurogastroenterol Motil 2017;29. [PMID: 27647462 DOI: 10.1111/nmo.12940] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
23 Mohammadzadeh N, Kalani BS, Bolori S, Azadegan A, Gholami A, Mohammadzadeh R, Masjedian Jazi F. Identification of an intestinal microbiota signature associated with hospitalized patients with diarrhea. Acta Microbiol Immunol Hung 2019;66:189-202. [PMID: 31062602 DOI: 10.1556/030.66.2019.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Durbán A, Abellán JJ, Jiménez-Hernández N, Salgado P, Ponce M, Ponce J, Garrigues V, Latorre A, Moya A. Structural alterations of faecal and mucosa-associated bacterial communities in irritable bowel syndrome. Environ Microbiol Rep. 2012;4:242-247. [PMID: 23757279 DOI: 10.1111/j.1758-2229.2012.00327.x] [Cited by in Crossref: 60] [Cited by in F6Publishing: 51] [Article Influence: 6.7] [Reference Citation Analysis]
25 Cojocariu RO, Balmus IM, Lefter R, Hritcu L, Ababei DC, Ciobica A, Copaci S, Mot SEL, Copolovici L, Copolovici DM, Jurcoane S. Camelina sativa Methanolic and Ethanolic Extract Potential in Alleviating Oxidative Stress, Memory Deficits, and Affective Impairments in Stress Exposure-Based Irritable Bowel Syndrome Mouse Models. Oxid Med Cell Longev 2020;2020:9510305. [PMID: 33425222 DOI: 10.1155/2020/9510305] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Salonen A, de Vos WM, Palva A. Gastrointestinal microbiota in irritable bowel syndrome: present state and perspectives. Microbiology. 2010;156:3205-3215. [PMID: 20705664 DOI: 10.1099/mic.0.043257-0] [Cited by in Crossref: 168] [Cited by in F6Publishing: 145] [Article Influence: 15.3] [Reference Citation Analysis]
27 Xiao Y, Liu Y, Huang S, Sun X, Tang Y, Cheng J, Wang T, Li F, Kuang Y, Luo R. The efficacy of Shugan Jianpi Zhixie therapy for diarrhea-predominant irritable bowel syndrome: a meta-analysis of randomized, double-blind, placebo-controlled trials. PLoS One. 2015;10:e0122397. [PMID: 25853241 DOI: 10.1371/journal.pone.0122397] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
28 El-Salhy M. Recent developments in the pathophysiology of irritable bowel syndrome. World J Gastroenterol 2015;21:7621-36. [PMID: 26167065 DOI: 10.3748/wjg.v21.i25.7621] [Cited by in CrossRef: 56] [Cited by in F6Publishing: 46] [Article Influence: 11.2] [Reference Citation Analysis]
29 Ng SC, Lam EF, Lam TT, Chan Y, Law W, Tse PC, Kamm MA, Sung JJ, Chan FK, Wu JC. Effect of probiotic bacteria on the intestinal microbiota in irritable bowel syndrome. J Gastroenterol Hepatol. 2013;28:1624-1631. [PMID: 23800182 DOI: 10.1111/jgh.12306] [Cited by in Crossref: 53] [Cited by in F6Publishing: 50] [Article Influence: 7.6] [Reference Citation Analysis]
30 Farjadian S, Fakhraei B, Moeini M, Nasiri M, Fattahi MR. Serotonin transporter gene polymorphisms in Southwestern Iranian patients with irritable bowel syndrome. Arab J Gastroenterol 2013;14:59-62. [PMID: 23820502 DOI: 10.1016/j.ajg.2013.03.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
31 Lee BJ, Bak YT. Irritable bowel syndrome, gut microbiota and probiotics. J Neurogastroenterol Motil. 2011;17:252-266. [PMID: 21860817 DOI: 10.5056/jnm.2011.17.3.252] [Cited by in Crossref: 103] [Cited by in F6Publishing: 85] [Article Influence: 10.3] [Reference Citation Analysis]
32 Rahimi R, Abdollahi M. Herbal medicines for the management of irritable bowel syndrome: a comprehensive review. World J Gastroenterol. 2012;18:589-600. [PMID: 22363129 DOI: 10.3748/wjg.v18.i7.589] [Cited by in CrossRef: 55] [Cited by in F6Publishing: 51] [Article Influence: 6.1] [Reference Citation Analysis]
33 Gerritsen J, Smidt H, Rijkers GT, de Vos WM. Intestinal microbiota in human health and disease: The impact of probiotics. Genes Nutr. 2011;6:209-240. [PMID: 21617937 DOI: 10.1007/s12263-011-0229-7] [Cited by in Crossref: 405] [Cited by in F6Publishing: 317] [Article Influence: 40.5] [Reference Citation Analysis]
34 Furnari M, de Bortoli N, Martinucci I, Bodini G, Revelli M, Marabotto E, Moscatelli A, Del Nero L, Savarino E, Giannini EG, Savarino V. Optimal management of constipation associated with irritable bowel syndrome. Ther Clin Risk Manag 2015;11:691-703. [PMID: 26028974 DOI: 10.2147/TCRM.S54298] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
35 Chong PP, Chin VK, Looi CY, Wong WF, Madhavan P, Yong VC. The Microbiome and Irritable Bowel Syndrome - A Review on the Pathophysiology, Current Research and Future Therapy. Front Microbiol. 2019;10:1136. [PMID: 31244784 DOI: 10.3389/fmicb.2019.01136] [Cited by in Crossref: 60] [Cited by in F6Publishing: 49] [Article Influence: 30.0] [Reference Citation Analysis]
36 Zhu JJ, Liu S, Su XL, Wang ZS, Guo Y, Li YJ, Yang Y, Hou LW, Wang QG, Wei RH, Yang JQ, Wei W. Efficacy of Chinese Herbal Medicine for Diarrhea-Predominant Irritable Bowel Syndrome: A Meta-Analysis of Randomized, Double-Blind, Placebo-Controlled Trials. Evid Based Complement Alternat Med. 2016;2016:4071260. [PMID: 27547226 DOI: 10.1155/2016/4071260] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
37 Tsang SW, Auyeung KK, Bian ZX, Ko JK. Pathogenesis, Experimental Models and Contemporary Pharmacotherapy of Irritable Bowel Syndrome: Story About the Brain-Gut Axis. Curr Neuropharmacol. 2016;14:842-856. [PMID: 27009115 DOI: 10.2174/1570159x14666160324144154] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
38 Bennet SM, Ohman L, Simren M. Gut microbiota as potential orchestrators of irritable bowel syndrome. Gut Liver. 2015;9:318-331. [PMID: 25918261 DOI: 10.5009/gnl14344] [Cited by in Crossref: 78] [Cited by in F6Publishing: 68] [Article Influence: 15.6] [Reference Citation Analysis]
39 Rajindrajith S, Zeevenhooven J, Devanarayana NM, Perera BJC, Benninga MA. Functional abdominal pain disorders in children. Expert Review of Gastroenterology & Hepatology 2018;12:369-90. [DOI: 10.1080/17474124.2018.1438188] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 5.7] [Reference Citation Analysis]
40 Chassard C, Dapoigny M, Scott KP, Crouzet L, Del'homme C, Marquet P, Martin JC, Pickering G, Ardid D, Eschalier A, Dubray C, Flint HJ, Bernalier-Donadille A. Functional dysbiosis within the gut microbiota of patients with constipated-irritable bowel syndrome. Aliment Pharmacol Ther. 2012;35:828-838. [PMID: 22315951 DOI: 10.1111/j.1365-2036.2012.05007.x] [Cited by in Crossref: 195] [Cited by in F6Publishing: 171] [Article Influence: 21.7] [Reference Citation Analysis]